ABSTRACT A uraemic patient undergoing chronic haemodialysis developed diffuse metastatic pulmonary calcification and died from acute respiratory insufficiency after renal transplantation. Thirteen similar cases previously published are reviewed, with emphasis on the clinical and anatomical features of such calcinosis. The pathogenesis of this calcification in patients on maintenance haemodialysis and some rules for its prevention are discussed.
Metastatic calcification in chronic renal failure has been well known since Virchow's first work in 1855. Such pathological calcification is either visceral or non-visceral. The former affects the muscles, the myocardium, and the lungs, whereas the latter is arterial, subcutaneous, or paraarticular.
With the advent of haemodialysis the manifestations of metastatic calcification have become prominent. Davidson and Pendras (1967) , McLachlan et al (1968) , Smith et al (1969) , Mootz et al (1973) , and Giacobetti et al (1977) have reported several cases of pulmonary metastatic calcification in patients undergoing chronic haemodialysis. We describe the case of a uraemic patient treated by chronic haemodialysis then renal transplantation who developed diffuse pulmonary micronodular calcification responsible for death from pulmonary insufficiency.
Case report
In 1955 urinalysis showed proteinuria in a 15-yearold boy. In 1969 gout occurred in the big toe, the knees and the ankles (serum urate was 112 mg/l).
The blood pressure was 170/100 mmHg. Intravenous pyelography and retrograde cystography confirmed the diagnosis of advanced interstitial chronic nephritis with massive vesicorenal reflux.
The blood urea was 110 mg/100 ml, creatinine clearance 12 ml/min, and proteinuria 1 g/24 hours. A low protein diet and a sodium administration did not stop his deterioration. Chronic haemodialysis was started in March 1970 Sao2 was about 82%. At that time diuresis was more than 2-61/day, serum creatinine 2-6 mg/ 100 ml, the urea 170 mg/100 ml without evidence of rejection.
After a stormy course, during which anticoagulants were started, haemorrhage occurred into the graft, and the patient died on 23 February 1975.
Post-mortem findings
The lung lesions were the main gross findings. The right and left lungs, weighing respectively 970 g and 800 g, were diffusely solidified and rigid. On cut sections numerous irregular greyish nodules were scattered through both lungs. These lesions were raised above the lung surface and were of gritty or firm consistency. They measured up to 0*5 cm in diameter. The heart weighed 520 g with left ventricular hypertrophy. Calcific deposits infiltrated the free edge of the anteromedial cusp of the mitral valve. The right kidney weighed 40 g, and its yellowish tissue contained several simple cysts. The 220 g transplanted kidney was congested. Neither tumour nor hyperplasia of parathyroid glands were found.
Microscopic examination showed a diffuse metastatic calcification in both lungs. The septa of alveoli were thickened by fibrosis, calcification, and macrophagic giant cells (figs 1 and 2). Some alveolar spaces were filled with fibroblasts or calcific concretions. Smaller calcific granulations were also discovered in the walls of bronchi or bronchioles and in the media of arterioles or venules (figs 3 and 4). No myocardial or arterial calcification was seen after hemalum-phloxine-safranin and Von Kossa's stain. The right kidney was destroyed by advanced unclassified nephropathy, and 5) . Some simple cysts were also present. The transplanted kidney showed signs of acute rejection.
Diffuse pulmonary calcinosis had induced death from acute respiratory failure after five years of chronic haemodialysis and in the days after renal transplantation. 
Discussion
Thirteen similar cases with diffuse pulmonary calcinosis have been reported in patients on maintenance haemodialysis or after renal transplantation or both. In seven of these cases death has occurred from lethal respiratory insufficiency (see  table) . E Justrabo, R Genin, and G Rifle
The visceral calcinosis is rarely present initially and is often unrecognised during life. Usually the diagnosis is made several months after the beginning of chronic haemodialysis and there is no parallel between the duration of chronic renal failure and the occurence of calcinosis (Conger, 1975) . In three cases calcific deposition has been diagnosed after renal transplantation (Kreis et al, 1976; Giacobetti et al, 1977 (Davidson and Pendras, 1967 , cases 1 and 2). Mootz et al (1973) and Giacobetti et al (1977) reported bony changes as osteitis fibrosa cystica in patients with four grossly and microscopically hyperplastic parathyroid glands. Examination of the kidneys shows a large number of chronic renal diseases. The basal membrane of the tubules and of the glomerular capsules is often thickened by calcific deposits.
Three hypotheses of the pathogenesis are considered. Firstly, the calcification is part of the natural history of the renal insufficiency and is promoted by tissue damage, such as by the pulmonary oedema of our patient and of others (cases 1 and 2 of McLachlan). Several patients, however, have no evident antecedent pulmonary lesions. So the role of humoral disorders that are constant seems more important. In all the observations Ca X P product (mg/l) exceeds 4500. If a predominant hypercalcaemia was noticed by Davidson and Pendras (1967) serum phosphate was highly increased in all the patients reported. The serum phosphate was 100 mg/100 ml for several years.
On the other hand, the high serum magnesium of uraemic patients may explain the chemical nature of the visceral calcification. In these cases, Contiguglia et al (1973) , using X-ray diffraction analysis of lung, heart, and muscle specimens, have shown that visceral calcification corresponds to an amorphous (Ca Mg)3 (PO 4)2 or whitlockite. Non-visceral and arterial calcifications are hydroxyapatite. Whitlockite is observed only in this medical condition (Gatter and McCarty, 1967) . So the part played by magnesium seems to be prominent: this cation inhibits the crystalline growth of apatite and, in contrast, stabilises whitlockite formation by decreasing its temperature of formation.
The alkaline conditions of kidney and lung favour deposition. Then at lung level the variations of blood pH from 7-35 to 7-45 decreases the phosphocalcific salt solubility by 10%. The severe changes of pH during haemodialysis may promote crystallisation.
It is difficult to specify the role of the hyperparathyroidism which is constant in uraemic patients. A parallelism between parathyroid hyperplasia and non-visceral calcification must exist, however (Contiguglia et al, 1973 ). This is not so for visceral calcifications.
Sometimes renal transplantation may increase the calcific deposition by calciphylaxis (Selye, 1962) . Calciphylaxis occurs after sensitisation of the organism with direct or indirect calcifiers, such as vitamin D and parathyroid hormone (Parfitt, 1969; Rubini et al, 1969) . The calcification appears after a critical period-exposure to a challenger or a precipitating factor such as steroids, calcium, or albumin. Giacobetti et al (1977) consider that the rapid development after renal graft of pulmonary calcification with documentation of normal lung by radiography six days before death supports the concept of acute deposition by calciphylaxis.
The lethal character of these calcific deposits call for careful monitoring, control of blood calcium, phosphate, and magnesium being the probable way to prevent tissue damage. Our observations and the others suggest the importance of raised magnesium and the part played by the association of pulmonary haemodynamic disorders. We propose, like Moinuddin et al (1976) and Schlangen and Pauwels (1976) , that dialysed patients with unexplained respiratory symptoms should undergo "bone scan" with 99mTc pyrophosphate for pulmonary calcifications. These authors think that bone scanning "is far more sensitive than conventional radiography for demonstration of pulmonary calcification." Finally, when visceral calcification is severe renal transplantation would seem the best solution. But we do not forget that this treatment can increase metastatic calcifications by calciphylaxis.
